 CAMBRIDGE, Mass. and GOSSELIES, Belgium, July 08, 2021 GLOBE NEWSWIRE -- iTeos Therapeutics, Inc. Nasdaq: ITOS, a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will participate in a panel discussion at the upcoming William Blair Biotech Focus Conference 2021 titled: Developing Therapies for the Next IO Targets on Wednesday, July 14, 2021 at 2:10 p.m. ET. 